CPT code 76932 designates the imaging supervision and interpretation associated with ultrasound guidance for an endomyocardial biopsy — a targeted cardiac procedure to obtain myocardial tissue. Nationally, accurate reporting of this code distinguishes imaging interpretation from the separately reportable biopsy procedure itself, affecting billing clarity, clinical documentation, and payer adjudication for cardiac interventional services.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will gain a concise overview of the clinical context for use of the code, typical sites of service where the procedure occurs, and the common payer landscape for coverage and adjudication. The publication outlines billing considerations relevant to documentation and reporting, summarizes typical modifier usage patterns where available, and situates 76932 within related cardiac procedural coding practices.

This summary is intended for a national audience of coding professionals, clinicians involved in cardiac procedures, and revenue cycle stakeholders seeking to understand when to report imaging supervision and interpretation separate from the endomyocardial biopsy procedure and what to review in payer policies and internal documentation workflows.